Skip to content

Histological evaluation of clinical effect of topical application of barberries dental gel on the gingival inflammation

Histological evaluation of clinical effect of topical application of barberries dental gel on the gingival inflammation

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138804302216N1
Enrollment
15
Registered
2009-10-26
Start date
2008-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis. Chronic periodontitis complex

Interventions

Intervention 1: Placebo gel, in soft splint, every night for two weeks. Intervention 2: Berberin gel, in soft splint, every night for two weeks.
Treatment - Drugs
Placebo gel, in soft splint, every night for two weeks
Berberin gel, in soft splint, every night for two weeks

Sponsors

Vice chancellery for research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients suffering from moderate to severe chronic periodontitis (according to AAP classification) referred to the Periodontology, Department of Mashhad University of Medical Sciences, Iran. Exclusion criteria: Presence of immunodeficiency, presence of diabetes, consumption of antibiotic during 3 months prior to study, using antibacterial mouth rinse, use of contraceptive drugs, presence of hematologic disorder, smoking

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement of gingivitis. Timepoint: Two week after use of test gel. Method of measurement: Surgery area and gum-biopsy specimens were obtained for the histological investigation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboobeh Shabzendedar

Dental School

shabzendedarm@mums.ac.ir+98 51 1882 9501

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026